3Kang M K, Park W, Choi Y L,et al. The effect of cyclooxygen-ase-2 expression on tumor volume response in patients treated withradiotherapy for uterine cervical cancer[ J] . J Korean Med Sci,2009,24(6):1170-6.
4Ma H I,Chiou S H, Hueng D Y,et al. Celecoxib and radioresis-tant glioblastoma-derived CD133 + cells : improvement in radio-therapeutic effects. Laboratory investigation [ J ]. J Neurosurg,2011, 114(3) :651 -62.
5Kang K B,Zhu C,Yong S K, et al. Enhanced sensitivity of cele-coxib in human glioblastoma cells : Induction of DNA damage lead-ing to p53-dependent G1 cell cycle arrest and autophagy [ J ]. MolCancer, 2009, 8 :66.
6Choy H, Milas L. Enhancing radiotherapy with cyclooxygenase-2enzyme inhibitor: a rational advance. [ J ]. J Natl Cancer Inst,2003,95(19):1440-52.
7Ettl T, Stiegler C,Zeitler K,et al. EGFR, HER2, survivin, andloss of pSTAT3 characterize high-grade malignancy in salivarygland cancer with impact on prognosis [ J]. Hum Pathol,2012 ,43(6):921 -31.
8Khan Z,Khan N,Tiwari R P,et al. Down-regulation of survivin byoxaliplatin diminishes radioresistance of head and neck squamouscarcinoma cells[ J]. Radiother Oncol,2010,96(2) :267 -73.
9Xiaoyuan C,Longbang C, Jinghua W, et al. Survivin: a potentialprognostic marker and chemoradiotherapeutic target for colorectalcancer[J].Ir J Med Sci,2010,179(3) ;327 -35.
10Joshi S, Ryan KM. Autophagy chews Fap to promote apoptosis[ J].Nat Cell Biol, 2014,16:23 -25.
